Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma.
Di Giorgio C, Lupia A, Marchianò S, Bordoni M, Bellini R, Massa C, Urbani G, Roselli R, Moraca F, Sepe V, Catalanotti B, Morretta E, Monti MC, Biagioli M, Distrutti E, Zampella A, Fiorucci S.
Di Giorgio C, et al. Among authors: lupia a.
Cells. 2022 Nov 3;11(21):3482. doi: 10.3390/cells11213482.
Cells. 2022.
PMID: 36359879
Free PMC article.